Home › Funds › Legato Capital Management LLC › MIRM

Legato Capital Management LLC position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

Legato Capital Management LLC reported holding 58,512 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$6.8M, representing 0.61% of its reported portfolio and ranking #20 among its reported holdings. Legato Capital Management LLC has disclosed MIRM holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)58.51K sh
Reported value held$6.85M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Legato Capital Management LLC's MIRM position evolved

Legato Capital Management LLC first disclosed a stake in MIRM in Q3 2023 at 36,317 shares (US$1.1M). The position peaked in Q2 2026 at 58,512 shares, worth US$6.8M. Across 11 filings, Legato Capital Management LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 58,512 shares valued at US$6.8M — an increase of 16,749 shares quarter over quarter.. Notable position changes include a 69% trim in Q1 2024 (shares rose 36% over the following quarter), a 92% increase in Q2 2025 (shares rose 44% over the following quarter), a 40% increase in Q2 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 36.32K $1.15M New
Q4 2023 39.81K $1.18M Add
Q1 2024 12.15K $305.28K Reduce
Q3 2024 12.42K $484.30K New
Q4 2024 13.39K $553.88K Add
Q1 2025 16.55K $745.67K Add
Q2 2025 31.76K $1.62M Add
Q3 2025 34.57K $2.53M Add
Q4 2025 44.12K $3.49M Add
Q1 2026 41.76K $3.86M Reduce
Q2 2026 58.51K $6.85M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 62 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has Legato Capital Management LLC held MIRM?

Legato Capital Management LLC has disclosed MIRM holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

What is Legato Capital Management LLC's current position in MIRM?

As of Q2 2026, Legato Capital Management LLC holds 58.51K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $6.85M, representing 0.61% of its reported portfolio and ranking #20.

Has Legato Capital Management LLC been buying or selling MIRM?

In the latest 13F filing (Q2 2026), Legato Capital Management LLC increased its position in MIRM. The position peaked in Q2 2026 at 58.51K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.